Ataque Cerebrovascular Isquémico con Criterios de Trombolisis en el Servicio de Emergencia del Hospital Edgardo Rebagliati Martins - ESSALUD, Agosto-Diciembre 2000. Valle Valverde, Luis.

REFERENCIA BIBLIOGRÁFICA

 

 

  1. Meschia, James F. MD. “Management of acute ischemic stroke. What is the role of tPA and  antithrombotic agents?” Vol 107 / Nº 6 / May 15, 2000 / POSTGRADUATE MEDICINE.

  2. National Institute of Neurological Disorders and Stroke, “Accidente Cerebrovascular: Esperanza en la Investigación” 2001.   www.ninds.org/acv.htm.

  3. Bargiela, Carlos Antonio, Ma. Bargiela. “Accidente Cerebro Vascular”. Revista de la Sociedad de Medicina Interna de Buenos Aires, 2000.      www.drwebsa.com.ar/smiba/med_inerna/vol_02/02_05.htm

  4. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333(24):1581-7

  5. Kwiatkowski TG, Libman RB, Frankel M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. N Engl J Med 1999;340(23):1781-7

  6. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998;352(9136):1245-51

  7. Lyden P, Brott T, Tilley B, et al. Improved reliability of the NIH Stroke Scale using video training. Stroke 1994;25(11):2220-6

  8. Quality Standards Subcommittee of the American Academy of Neurology. Practice advisory: thrombolytic therapy for acute ischemic stroke--summary statement. Neurology 1996;47(3):835-9

  9. Albers GW, Bates VE, Clark WM, et al. Intravenous tissue-type plasminogen activator for  treatment of acute stroke: the Standard Treatment for Alteplase to Reverse Stroke (STARS) study.  JAMA 2000;283(9):1145-50

  10. Brott T, Lu M, Kathari R, et al. Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke 1998;29(8):1504-9

  11. National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. A systems approach to immediate evaluation and management of hyperacute stroke: experience at  eight centers and implications for community practice and patient care. Stroke 1997;28(8):1530-40

  12. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the  PROACT II study. JAMA 1999;282(21):2003-11

  13. Gonner F, Remonda L, Mattle H, et al. Local intra-arterial thrombolysis in acute ischemic stroke. Stroke 1998;29(9):1894-900

  14. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised  trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet 1997;349(9065):1569-81

  15. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet 1997;349(9066):1641-9

  16. Dippel DW. The results of CAPRIE, IST and CAST. Thromb Res 1998;92(1 Suppl 1):S13-6

  17. Adams HP Jr, Bendixen BH, Leira E, et al. Antithrombotic treatment of ischemic stroke among patients with occlusion of severe stenosis of the internal carotid artery: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999;53(1):122-5

  18. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342(8882):1255-62

  19. Lip GY, Beevers DG. Interpretation of IST and CAST stroke trials. (Letter) Lancet       1997;350(9075):442-3

  20. Alberts MJ. t-PA in acute ischemic stroke: United States experience and issues for the future.Neurology 1998;51(3 Suppl 3):S53-5

  21. DePippo KL, Holas MA, Reding MJ. Validation of the 3-oz water swallow test for aspiration following stroke. Arch Neurol 1992;49(12):1259-61

  22. Turpie AG. Prophylaxis of venous thromboembolism in stroke patients. Semin Thromb Hemost 1997;23(2):155-7

  23. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974;2(7872):81-4

  24. Carter BS, Ogilvy CS, Candia GJ, et al. One-year outcome after decompressive surgery for  massive nondominant hemispheric infarction. Neurosurgery 1997;40(6):1168-76

  25. Kwakkel G, Wagenaar RC, Koelman TW, et al. Effects of intensity of rehabilitation after stroke: a research synthesis. Stroke 1997;28(8):1550-6

  26. Stroke Unit Trialists' Collaboration. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. BMJ 1997;314(7088):1151-9

  27.  Stroke Unit Trialists' Collaboration. How do stroke units improve patient outcomes? A   collaborative systematic review of the randomized trials. Stroke 1997;28(11):2139-44

  28. Alberts MJ, Chaturvedi S, Graham G, et al. Acute stroke teams: results of a            national survey. Stroke 1998;29(11):2318-20

  29. Hachinski V. Thrombolysis in acute stroke. Arch Neurol 1996;53(12):1308.

  30. Bayona Hernán, Toro Jaime. Guías de Manejo de Trombolisis. Página web. Mayo. 2002.

  31. Mellado T. Patricio. Enfermedad Cerebrovascular. Apuntes de Medicina Intensiva. PUC Chile. Facultad de Medicina. Programa de Medicina intensiva. Abril, 2002.                                        http://escuela.med.puc.cl/paginas/publicaciones/medicinaintensiva/enfermedad.htm

 


Contenido Relación por área Relación por autor